Descripción de las caracteristicas clínicas de las neoplasias mieloproliferativas crónicas (NMPC). Primer informe del registro colombiano de NMPC

Abello, Virginia; Quintero, Guillermo; Espinosa, Daniel; Solano, María Helena; Casas, Claudia Patricia; Saavedra, Domingo; Quintero, Mario; Lobatón, Jose Fernando; Sossa, Claudia; Peña, Ángela; Lopera, Diego; Romero, Ricardo.
Acta méd. colomb ; 42(1): 35-41, ene.-mar. 2017. tab, graf
Artículo en Español | LILACS, COLNAL - Colombia-Nacional | ID: biblio-886337

Documentos relacionados

  1. Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
  2. Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis.
  3. A Novel Morphological Parameter Predicting Fibrotic Evolution in Myeloproliferative Neoplasms: New Evidence and Molecular Insights.
  4. JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms.
  5. [Search for mutations in patients with Philadelphia negative myeloproliferative neoplasms in a public hospital in Chile].
  6. Labor market affiliation of patients with myeloproliferative neoplasms: a population-based matched cohort study.
  7. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
  8. Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes.
  9. The differences of hemogram, myelogram, and driver gene mutations in classic myeloproliferative neoplasms.
  10. Top advances of the year: Myeloproliferative neoplasms.